Bone-specific response according to mda criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (nsclc) patients

HIGHLIGHTS

  • who: Andrea De Giglio from the Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via Giuseppe Massarenti, , Bologna, Italy have published the article: Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients, in the Journal: (JOURNAL)
  • what: This work aimed to explore the use of MDA criteria in the evaluation of response in NSCLC patients with Journal of Cancer Research and Clinical Oncology 149:1835-1847 bone metastasis.
  • how: The authors conducted a single-center retrospective study to assess the use . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?